Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer. | Acta Pharm Sin B | 2021 | 34221872 | PubTator, text mining | PubMed |
| Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation. | Eur J Med Chem | 2021 | 34217059 | PubTator, text mining | PubMed |
| Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform. | Commun Biol | 2021 | 34215850 | PubTator, text mining | PubMed |
| Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation. | RSC Chem Biol | 2021 | 34212149 | PubTator, text mining | PubMed |
| Targeted Cancer Therapy Using Compounds Activated by Light. | Cancers (Basel) | 2021 | 34209493 | PubTator, text mining | PubMed |
| An Overview on Diffuse Large B-Cell Lymphoma Models: Towards a Functional Genomics Approach. | Cancers (Basel) | 2021 | 34207773 | PubTator, text mining | PubMed |
| The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients. | J Clin Med | 2021 | 34207079 | PubTator, text mining | PubMed |
| Hydrophobic Tagging-Mediated Degradation of Transcription Coactivator SRC-1. | Int J Mol Sci | 2021 | 34203850 | PubTator, text mining | PubMed |
| Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors. | Cancers (Basel) | 2021 | 34203106 | PubTator, text mining | PubMed |
| Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma. | Cancers (Basel) | 2021 | 34203062 | PubTator, text mining | PubMed |
| Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases. | Life (Basel) | 2021 | 34202541 | PubTator, text mining | PubMed |
| CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers. | Cancers (Basel) | 2021 | 34201346 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma. | J Med Chem | 2021 | 34196564 | PubTator, text mining | PubMed |
| Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead. | Front Oncol | 2021 | 34195095 | PubTator, text mining | PubMed |
| CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function. | Cancer Immunol Res | 2021 | 34193461 | PubTator, text mining | PubMed |
| Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies. | J Hematol Oncol | 2021 | 34193230 | PubTator, text mining | PubMed |
| Exploiting the CRISPR-Cas9 gene-editing system for human cancers and immunotherapy. | Clin Transl Immunology | 2021 | 34188916 | PubTator, text mining | PubMed |
| Updates in the Treatment of Peripheral T-Cell Lymphomas. | J Exp Pharmacol | 2021 | 34188559 | PubTator, text mining | PubMed |
| Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity. | Blood Res | 2021 | 34187943 | PubTator, text mining | PubMed |
| Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma. | NPJ Precis Oncol | 2021 | 34183722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=78